Sanyo dual-cooling freezer provides sample security

Published: 30-Jun-2011
Manufacturing Research & Development

The upright 728l model is ideal for valuable research or clinical samples

Sanyo has expanded its range of dual-cooling -86°C freezers with the launch of the extra-large capacity MDF-U700VX, an upright 728 litre model which provides maximum sample security for valuable research or clinical samples.

With two independent refrigeration systems the dual-cooling freezers maintain a reliable and uniform -86°C ultralow temperature environment. Should one cooling system suffer an unexpected failure, the other circuit will keep irreplaceable samples safely around -70°C until service can be arranged. This freezer design not only protects precious samples but also prevents the inconvenience and expense of out-of-hours call-outs in the event of a failure of one of the refrigeration systems.

The MDF-U700VX has an extra-large capacity of 728 litres without taking up extra space, thanks to its VIP Plus high efficiency vacuum insulation. In addition to reducing energy use, VIP Plus provides typically 24% more storage capacity compared with a conventionally insulated freezer with the same footprint.

This latest dual-cooling unit offers Sanyo’s industry-first intelligent ECO Mode, optimising compressor operation to match the freezer’s running conditions and minimise energy use. Efficient long-term operation of the freezer is facilitated by the filter-less condenser design, which eliminates the need for routine filter cleaning.

The central door-mounted LCD display panel provides intuitive programming of set points and clear confirmation of freezer status. An on-board data logging function allows the operator to easily check recent freezer performance. Other user-friendly design features include comprehensive alarms, a vacuum release port for smooth door opening, and quiet operation.

The MDF-U700VX is certified as a Class IIa Medical Device (93/42/EEC and 2007/47/EC).

See more

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

Read more
For use in high humidity conditions

Trending Articles

  1. Stipple Bio enters into multi-target license agreement with Lonza to advance precision oncology ADC therapies Stipple Bio’s Pointillist Platform identifies tumour-specific cell surface epitopes that, when combined with Lonza’s clinically validated ADC platform, may enable first-in-class and best-in-class ADC oncology medicines such as STP-100
  2. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  3. Lonza advances integrated DNA‑to‑IND programmes with acceleration, derisking and innovation New GS Ori‑Go vector technology supports titers higher than 11 g/L and reliable bulk pool stability, enabling more predictable material generation and shortened cell line development timelines
  4. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

For use in high humidity conditions
Containment

Sanyo installs first cell processing workstation in US

To be used to advance stem cell and cell therapy research at the University of Alabama at Birmingham
Manufacturing

Sanyo incubator offers uniform culturing environment

Includes optional hydrogen peroxide decontamination system
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

The path to commercial allogeneic iPSC therapies

The cell therapy sector is currently shifting from patient-specific autologous treatments toward off-the-shelf allogeneic cell therapies. Although this transition is helping to democratise access to treatments, it introduces several challenges in terms of controlling complex biology at a commercial scale
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Subscribe now